2024-01-30 11:44:17 ET
Summary
- Certara is a major player in the biosimulation industry and has a strong position in the market.
- Despite recent financial challenges, Certara's overall business effectiveness remains undeniable.
- The company's strategic acquisitions and expansions, along with its innovative software products, position it well for future growth in the healthcare technology sector.
?Drug development is unimaginable without the use of biosimulation, and Certara ( CERT ) has become a major player in this area. ??Despite the recent poor financial performance of this company where revenue showed only a small increase but net loss increased significantly due to a one-time charge, its overall business effectiveness is still undeniable. ??Despite the arguably poor economics, there continues to be a high demand for Certara's biosimulation software and services. ?...
Read the full article on Seeking Alpha
For further details see:
Certara: Applied BioMath Acquisition And Simcyp Launch Should Drive Growth